CATIE HepC Info Update 3.5

Check out CATIE’s HepC Info Update 3.5:

  • Hepatitis C advocates call for early studies of interactions with new hepatitis C virus drugs
  • Drug users’ union in San Francisco seeks voice in policy
  • Hepatitis C in baby boomers remains silent epidemic
  • FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury
  • Telaprevir and boceprevir improve sustained virological response rates in people co-infected with HIV/hepatitis C
  • Study shows how interferon fights HIV along with hepatitis C in people who are co-infected

As well as:

  • Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: A systematic review and meta-Analysis – Liver Transplantation, March 2012, in English
  • Case-control study of hepatitis B and hepatitis C in older adults: Do healthcare exposures contribute to burden of new infections? – Hepatology, March 2012, in English
  • Peg-interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial – Hepatology, March 2012, in English
  • Future treatment of patients with hepatitis C virus cirrhosis – Liver International, February 2012, in English

View the full update here.